Review ArticleInternational Journal of Contemporary Pediatrics
Publication: Effectiveness of riboflavin as prophylaxis of paediatric migraine
Int J Contemp Pediatr. 2023;10(12):1881-1885.DOI10.18203/2349-3291.ijcp20233545
Abstract
Paediatric migraine headache is a common condition for which there is no general consensus on the choice of prophylactic. Riboflavin has been considered as a potential prophylactic which is well tolerated. This review examines the current literature regarding the efficacy of riboflavin as a prophylactic. There have been mixed results from both retrospective studies as well as randomised controlled trials. Whilst the adverse effect profile is minimal compared to other migraine prophylactics, further well-designed studies with larger sample sizes and longer follow-up are required.
Keywords
Affiliations
- Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom
